Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.
USOR 25156 - ACCELERO: Ph3 PF-08634404 + Chemo vs Pembro + Chemo in Locally Advanced or Metastatic NSCLC
AN INTERVENTIONAL PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Disease Types: Colorectal
Available at: Arlington Heights, Chicago, Niles

